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Information on problem drug use is collected by the National Drug Treatment Reporting
System (NDTRS). The NDTRS is an epidemiological database on treated drug misuse. It was
established in 1990 in the Greater Dublin Area only. In 1995 it was extended to other parts
of the country including the Mid Western Health Board (MWHB) area. The objectives of the
NDTRS are to provide reliable information on the number and characteristics of people
who are treated for problem drug use; and to examine trends and patterns of problem
drug use. It provides information relevant to the health consequences and social
implications of drug misuse and contributes to an understanding of the epidemiology of
drug misuse in Ireland. This series of papers presents data by regional health board areas.
NDTRS methodology
Background
Data on treated drug misuse are routinely collected by staff at drug treatment agencies
throughout Ireland. In the MWHB area data collection is co-ordinated by a Regional Co-ordinator.
Compliance with the NDTRS requires that a form be completed for each person who receives
treatment for problematic drug use. At national level, anonymous, aggregated data are compiled
by the Drug Misuse Research Division (DMRD), Health Research Board (HRB).
For the purpose of the NDTRS, treatment is broadly defined as ‘any activity which aims to
ameliorate the psychological, medical or social state of individuals who seek help for their drug
problems’. Treatment may therefore include non-medical (addiction counselling, group
therapy, psychotherapy), as well as medical interventions (detoxification, methadone
substitution programmes).  
The main elements of the reporting system are: 
a) All Treatment Contacts – the reporting of all clients receiving treatment during a given year,
and 
b) First Treatment Contacts – the reporting of the sub-group of clients who have never previously
been treated for problem drug use.
In the case of the ‘all contact’ data there is a possibility of duplication in the database, for example,
where a person receives treatment at more than one centre. This is estimated to be small since the
introduction of the Misuse of Drugs Regulations in 1998, whereby precautions are taken to ensure
that treatment by way of medical prescription is available from one source only.
Treatment as an indicator of drug misuse
Drug treatment data are viewed as an indirect indicator of drug misuse and are used at
national and European levels to provide information on the characteristics of clients
entering treatment, and patterns of drug misuse such as types of drugs used and
consumption behaviours. They are ‘valuable from a public health perspective to assess
needs, … and to plan and evaluate services’ (EMCDDA, 1998: 23). Information from the
NDTRS is made available to service providers and policy makers and forms an important
Table 1a. Number of All Treatment Contacts* by treatment area and area of residence of clients,
1996-2000
Year Total treated in MWHB MWHB residents MWHB residents Others treated in Total MWHB residents
treated in MWHB treated elsewhere MWHB treated
1996 83 37 8 46 45
1997 210 94 8 116 102
1998 200 79 17 121 96
1999 281 139 21 142 160
2000 327 176 28** 151 204**
* Number of cases, as distinct from individuals, who received treatment for their problem drug use
** Provisional figures due to incomplete returns from the Eastern Regional Health Authority health boards
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The emphasis of drug policy in the MWHB area is on prevention and health promotion (http://www.mwhb.ie).
The Health Promotion team of the MWHB operates the Sláinte Health Advice Centre to cater for the health
information needs of the general public. A Drug Strategy Co-ordinator was appointed in 1999 to formulate
and develop a drug strategy for the region. Training in drug and alcohol related issues is available to teachers,
youth workers, community workers, Gardaí and others.
Drug treatment services in the MWHB area are provided through the Drug and Alcohol Counselling Service at
Sláinte Health Advice Centre; by Addiction Counsellors at day hospitals and residential treatment centres. Data
for the NDTRS during 2000 were collected by 10 agencies: 3 residential, including 1 psychiatric hospital; and 7
non-residential centres. Out of a total of 327 contacts during 2000, 197 were treated at residential centres,
and 130 at non-residential centres. The type of drug treatment provided/availed of was mainly
advice/counselling/support (N=317). The treatment provided to any one individual may include a combination
of treatment options. During 2000, as well as addiction counselling, over half of clients (N=195) received
‘medicament free/psychosocial therapy’; 18 clients underwent detoxification; and 2 were treated in a drug
substitution/maintenance programme.  
Extent of the problem
1 Counties Clare, Limerick and Tipperary North Riding
2 The emphasis of this paper is on the illicit drug use of clients who received treatment between 1996 and 2000, in the catchment area covered
by the MWHB (Counties Clare, Limerick and Tipperary North Riding)
Treatment provision
element in informing local and national drug policies. Based on NDTRS data a number of local areas
were targeted for special attention in 1996 (Ministerial Task Force, 1996). Initially eleven areas, ten in
Dublin and one in Cork, all of which were characterised by social and economic disadvantage, were
designated as Local Drug Task Force Areas (Ministerial Task Force, 1996). There are now fourteen areas:
twelve in Dublin; one in Cork; and one in Bray (Department of Tourism, Sport & Recreation, 2001).
Local Drug Task Forces were established with the aim of providing strategic local responses in areas
where drug misuse was a serious problem.
In the Government’s Building on Experience. National Drugs Strategy 2001-2008, the role of the NDTRS is
recognised in ensuring that the overall aims of the strategy are met. NDTRS data collection is one of the
actions identified and agreed by Government for implementation by health boards. It is stated that ‘all
treatment providers should co-operate in returning information on problem drug use to the DMRD of
the HRB’ (Department of Tourism, Sport & Recreation, 2001: 118). 
The emphasis of
drug policy in
the MWHB area
is on prevention
and health
promotion 
During 2000,
204 MWHB
residents were
treated for
problematic
drug use
In 1996 the number of drug users presenting for treatment2 in the MWHB area was 83 (Table 1a). In 1997
this had increased to 210; and by 2000 the number had reached 327. Each year a high proportion (around
half) of people treated in the MWHB for problem drug use are from outside the area. In 2000, for example,
out of the total of 327 treated in the region, 151 (46 percent) were not residents of the MWHB catchment
area (Table 1a). These clients were mainly from Eastern Regional Health Authority (ERHA) (N=64) and
Southern Health Board (SHB) (N=45) areas. This may indicate a preference for the type of treatment
services on offer in the area. A relatively small number of people from the MWHB area are treated outside of
the region – for example, in 2000, 28 MWHB residents were treated elsewhere (Table 1a). 
Table 1b. Number of First Treatment Contacts* by treatment area and area of residence of 
clients, 1996-2000
Year Total treated in MWHB MWHB residents MWHB residents Others treated in Total MWHB residents
treated in MWHB treated elsewhere MWHB treated
1996 59 30 6 29 36
1997 84 54 3 30 57
1998 110 50 7 60 57
1999 127 74 17 53 91
2000 174 96 16** 78 112**
* Number of people who received treatment for the first time ever
** Provisional figures due to incomplete returns from the Eastern Regional Health Authority health boards
Table 2a. Socio-demographic characteristics of All Treatment Contacts treated in the MWHB, 
1996-2000
Characteristics 1996 1997 1998 1999 2000
% Males : % Females 85:15 67:33 72:28 75:25 81:19
Mean age (years) 23 23 24 25 24
Modal age (years) 18 17 18 23 19
% Under 18 years of age 7 16 5 9 10
% Living with parents/family 46 58 53 67 67
% Early school leavers* 32 26 11 18 20
% Still at school 0 8 2 7 6
% Employed 13 22 18 17 21
* Left school before the age of 15 years
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The typical client coming for treatment is male, in his late teens or early twenties and living in the family
home. The mean age for all contacts was stable over the five-year period under review, at around 24
years of age (Table 2a). The social conditions of clients improved over the period 1996 to 2000. By 2000
they were less likely to have left school before the official school leaving age of 15 years (20 percent)
compared to 1996 (32 percent) (Table 2a). Clients were also less likely to be unemployed, with
employment levels improving from 13 percent in 1996 to 21 percent in 2000. This is as might be
expected, given the general favourable economic conditions in the country. However, these statistics are
indicative of the social disadvantage of drug users, and present a challenge to policy makers if social
exclusion and marginalisation issues are to be addressed.     
Socio-demographic information
About half of all those presenting each year in the MWHB are receiving treatment for problematic drug
use for the first time (first contacts). The number of first contacts increased from 59 in 1996 to 174 in
2000 (Table 1b). A little less than half of new clients are from elsewhere (78 out of 174 in 2000).   
The socio-demographic characteristics of new clients (first contacts) are generally quite similar to those of
the overall group of all contacts (Table 2b).    
The typical 
client coming 
for treatment is
male, in his late
teens or early
twenties and
living in the
family home
Table 2b. Socio-demographic characteristics of First Treatment Contacts treated in the MWHB, 
1996-2000
Characteristics 1996 1997 1998 1999 2000
% Males : % Females 86:14 68:32 74:26 76:24 81:19
Mean age (years) 23 22 23 22 23
Modal age (years) 18 19 18 20 19
% Under 18 years of age 7 14 7 15 12
% Living with parents/family 51 61 61 73 73
% Early school leavers* 26 16 12 13 17
% Still at school 0 10 2 12 6
% Employed 14 23 18 21 23
* Left school before the age of 15 years
Table 3a. Main Drug of Misuse of All Treatment Contacts treated in the MWHB, 1996-2000  
Main Drug of 1996 1997 1998 1999 2000
Misuse N (%) N (%) N (%) N (%) N (%)
Opiates 27 (33) 68 (33) 69 (35) 84 (30) 87 (27)
Cocaine 1 (1) 4 (2) 13 (7) 3 (1) 12 (4)
Ecstasy 18 (22) 39 (19) 24 (12) 21 (8) 26 (8)
Amphetamines 1 (1) 13 (6) 11 (6) 8 (3) 3 (1)
Benzodiazepines 1 (1) 10 (5) 11 (6) 6 (2) 7 (2)
Volatile Inhalants 1 (1) 6 (3) 1 (1) 7 (3) 8 (2)
Cannabis 27 (33) 57 (27) 66 (33) 146 (52) 172 (53)
Other substances 7 (8) 12 (6) 5 (3) 6 (2) 12 (4)
Total 83 210* 200 281 327
* Percentages based on valid N of 209
Table 3b. Main Drug of Misuse of First Treatment Contacts treated in the MWHB, 1996-2000 
Main Drug of 1996 1997 1998 1999 2000
Misuse N (%) N (%) N (%) N (%) N (%)
Opiates 15 (25) 19 (23) 39 (35) 28 (22) 36 (21)
Cocaine 1 (2) 1 (1) 1 (1) 1 (1) 6 (3)
Ecstasy 16 (27) 19 (23) 15 (14) 11 (9) 15 (9)
Amphetamines 0 (0) 6 (7) 9 (8) 5 (4) 1 (1)
Benzodiazepines 0 (0) 0 (0) 2 (2) 2 (2) 1 (1)
Volatile Inhalants 0 (0) 1 (1) 0 (0) 2 (2) 4 (2)
Cannabis 22 (37) 34 (41) 43 (39) 76 (60) 102 (59)
Other substances 5 (8) 3 (4) 1 (1) 2 (2) 9 (5)
Total 59 84* 110 127 174
* Percentages based on valid N of 83
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Information on the patterns of drug use, such as the types of drugs used, how they are taken, and whether
in combination with other drugs, can be useful in assessing and planning drug treatment services. In the
MWHB area, drug use patterns are generally similar to those in other regions of the country where
cannabis is the main drug causing problems and for which most people present for treatment (O’Brien et
al. 2000). Trends over the period 1996 to 2000 show that cannabis misuse is on the increase, from 33
percent in 1996 to 53 percent in 2000 (Table 3a). Given that cannabis is smoked, this can have serious
implications for the future health of a young population. Unlike most other regions where cannabis is
usually followed by ecstasy as the main drug of misuse, in the MWHB cannabis is followed by opiates as
the main drug of choice. While the number of opiate contacts has increased (from 27 in 1996 to 87 in
2000), the proportion has decreased from 33 percent in 1996 to 27 percent in 2000. Over the same
period there was a decrease in ecstasy use, from 22 percent to 8 percent (Table 3a).  
Problem drug use
Trends among the sub-group of new clients (first contacts) were similar to those of the overall group (all
contacts) (Table 3b). New clients were more likely to be using cannabis than the overall group. This
could perhaps be explained in part by the expansion of treatment services, which are more accessible to
young cannabis users. Ecstasy use among new clients decreased from 27 percent in 1996 to 9 percent in
2000. Opiate use trends among new clients were similar to those of all contacts (Table 3b).   
A closer scrutiny of all treatment contacts reveals that heroin was the opiate most likely to be used and
that the number is on the increase, from 26 in 1996 to 82 in 2000 (Table 4a). The fact that in 2000 heroin
was more likely to be injected (by 50 out of 82 contacts) than smoked has serious health implications. 
Trends over the
period 1996 to
2000 show that
cannabis misuse is
on the increase
Table 4a. Opiate as a Main Drug of Misuse for All Treatment Contacts treated in the MWHB, 1996-2000
Main Drug / Route 1996 1997 1998 1999 2000
of Administration N N N N N
Heroin 26 60 66 78 82
of whom:
inject 17 29 48 54 50
smoke 9 24 15 17 29
other route 0 2 1 5 0
not known 0 5 2 2 3
Other Opiates 1 8 3 6 5
Total 27 68 69 84 87
Table 4b. Opiate as a Main Drug of Misuse for First Treatment Contacts treated in the MWHB, 
1996-2000
Main Drug / Route 1996 1997 1998 1999 2000
of Administration N N N N N
Heroin 15 18 36 28 34
of whom:
inject 11 8 25 19 19
smoke 4 9 10 7 14
other route 0 0 0 1 0
not known 0 1 1 1 1
Other Opiates 0 1 3 0 2
Total 15 19 39 28 36
Table 5a. Secondary Drug of Misuse of All Treatment Contacts treated in the MWHB, 1996-2000 
Secondary Drug 1996 1997 1998 1999 2000
of Misuse N (%) N (%) N (%) N (%) N (%)
No second drug 8 (10) 40 (19) 20 (10) 55 (20) 87 (27)
Opiates 14 (17) 19 (9) 25 (13) 12 (4) 17 (5)
Cocaine 3 (4) 9 (4) 9 (5) 18 (6) 12 (4)
Ecstasy 14 (17) 46 (22) 46 (23) 72 (26) 71 (22)
Amphetamines 6 (7) 18 (9) 29 (15) 24 (9) 13 (4)
Benzodiazepines 2 (2) 10 (5) 6 (3) 4 (1) 4 (1)
Volatile Inhalants 1 (1) 2 (1) 0 (0) 2 (1) 3 (1)
Cannabis 11 (13) 44 (21) 27 (14) 50 (18) 76 (23)
Alcohol 9 (11) 9 (4) 18 (9) 11 (4) 8 (2)
Other substances 15 (18) 11 (5) 20 (10) 33 (12) 36 (11)
Total 83 210* 200 281 327
* Percentages based on valid N of 208
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Among new clients the number of heroin users more than doubled from 15 in 1996 to 34 in 2000 (Table
4b). More than half (19 out of 34) had injected the heroin in 2000.
Polydrug use is very much a feature of clients’ behaviour, with nearly three-quarters of clients (73
percent) in 2000 involved in the use of more than one drug (Table 5a). However, polydrug use seems to
be a decreasing trend in the MWHB, from 90 percent in 1996 to 73 percent in 2000. Very few cases of
alcohol3 use are reported, and considering that alcohol use was the main problem highlighted in a survey
of teenagers in the Mid West in 1997 (Gleeson et al., 1998), it is somewhat surprising that this is not
reflected in returns to the NDTRS. 
Heroin
contacts
increased
from 26 in
1996 to 82 
in 2000
Polydrug use
is very much
a feature of
clients’
behaviour
There are similar trends in polydrug use among new clients (Table 5b).   
3 Alcohol may be included as a secondary drug of misuse in the NDTRS. It is NOT included as a main drug
Table 6a. Risk Behaviours of All Treatment Contacts treated in the MWHB, 1996-2000
Risk Behaviours 1996 1997 1998 1999 2000
Mean age of initial drug use (years) 15 15 15 15 15
Mean age 1st injected (years) 19 19 18 18 18
Ever Injected  N 19 36 58 69 64
of whom:
‘ever shared’  N 15 29 28 13 10
‘currently injecting’  N 15 29 14 29 29
‘currently sharing’  N 6 14 6 2 4
Table 6b. Risk Behaviours of First Treatment Contacts treated in the MWHB, 1996-2000
Risk Behaviours 1996 1997 1998 1999 2000
Mean age of initial drug use (years) 15 15 15 15 15
Mean age 1st injected (years) 20 18 17 17 18
Ever Injected  N 12 10 31 22 23
of whom:
‘ever shared’  N 10 8 12 4 3
‘currently injecting’  N 8 9 4 8 12
‘currently sharing’  N 3 5 1 1 2
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Over the five-year period the mean age of initial drug use remained consistently young at 15 years of age
(Tables 6a, 6b). The number of clients who had injected at some time was relatively low, but increased
from 19 in 1996 to 64 in 2000 (Table 6a). While the numbers who had ever injected are increasing, there
is a proportional decrease in those involved in high risk behaviour. The number who had ever shared
injecting equipment dropped from 15 in 1996 to 10 in 2000 (Table 6a). However, those currently
involved in injecting drug use increased from 15 in 1996 to 29 in 2000, indicating that there is no room
for complacency.   
Risk behaviour
Among the first contact sub-group the number who had ever injected is relatively small. However, it is
increasing (from 12 in 1996 to 23 in 2000), and the fact that they are involved in high risk behaviour
such as injecting drugs cannot be ignored (Table 6b).   
Table 5b. Secondary Drug of Misuse of First Treatment Contacts treated in the MWHB, 1996-2000
Secondary Drug 1996 1997 1998 1999 2000
of Misuse N (%) N (%) N (%) N (%) N (%)
No second drug 6 (10) 20 (24) 8 (7) 24 (19) 41 (24)
Opiates 8 (14) 5 (6) 15 (14) 2 (2) 9 (5)
Cocaine 2 (3) 0 (0) 2 (2) 8 (6) 6 (3)
Ecstasy 10 (17) 22 (27) 29 (26) 41 (32) 49 (28)
Amphetamines 6 (10) 7 (8) 20 (18) 13 (10) 7 (4)
Benzodiazepines 1 (2) 1 (1) 0 (0) 3 (2) 3 (2)
Volatile Inhalants 1 (2) 1 (1) 0 (0) 2 (2) 1 (1)
Cannabis 7 (12) 17 (20) 14 (13) 19 (15) 37 (21)
Alcohol 8 (14) 5 (6) 14 (13) 5 (4) 3 (2)
Other substances 10 (17) 5 (6) 8 (7) 10 (8) 18 (10)
Total 59 84* 110 127 174
* Percentages based on valid N of 83
Mean age of
initial drug use
remained
consistently
young at 15
years of age
Trends in Treated Drug Misuse in the Mid Western Health Board Area, 1996-2000
7
Figure 1a. Trends in All Treatment Contact rates for 15 - 39 year olds by Health Board of 
Residence, 1996-2000*. Rates per 10,000 population **
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Figure 1b. Trends in First Treatment Contact rates for 15 - 39 year olds by Health Board of 
Residence, 1996-2000*. Rates per 10,000 population **
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* Trends for 1996-1999 only in the EHB due to incomplete returns for 2000
** Population figures for each health board are based on the Census for Population 1996, Central Statistics Office
* Trends for 1996-1999 only in the EHB due to incomplete returns for 2000
** Population figures for each health board are based on the Census for Population 1996, Central Statistics Office
Year
Figures 1a and 1b provide a comparison of the rates of treated drug misuse among residents in different health
board areas of Ireland for all and first treatment contacts respectively. As the majority of people treated for
problem drug use are in the 15-39 year age group, the rates were based on this age group of the population
in each health board area. It is immediately obvious that in the ERHA health board areas (formerly EHB) the
rate is much higher than in other regions of the country. However, there is not great variation in regional
trends. In all cases the trend shows an increase in those presenting to drug treatment services (Figure 1a).       
Regional trends
There was an upward trend in first treatment contacts between 1996 and 2000 in all regions (Figure
1b). Increased provision of services at individual health board level is of course a factor that must be
borne in mind when considering such trends. Where there are accessible drug user oriented services
provided, people are more likely to approach them. However, it would appear that the upward trends
also indicate a real increase in drug misuse.   
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